Inside laboratories far removed from the public debate about artificial intelligence, a quieter revolution is unfolding — one measured not in headlines but in years returned to human lives. AI systems are compressing drug discovery timelines that once spanned decades into mere days, with recent breakthroughs reversing molecular aging markers by half a century and uncovering hidden therapeutic value in medicines long since abandoned by profit-driven research. The technology is not supplanting the scientist but extending their reach into a vastness of molecular possibility that no human mind cou